Testosterone Serum Levels Are Related to Sperm DNA Fragmentation Index Reduction after FSH Administration in Males with Idiopathic Infertility
暂无分享,去创建一个
D. Santi | G. Spaggiari | M. Simoni | P. Drakopoulos | F. Caprio | N. Colacurci | M. Lispi
[1] D. Santi,et al. Real-world evidence analysis of the follicle-stimulating hormone use in male idiopathic infertility. , 2022, Best practice & research. Clinical obstetrics & gynaecology.
[2] P. Patel,et al. An update on male infertility and intratesticular testosterone—insight into novel serum biomarkers , 2022, International Journal of Impotence Research.
[3] E. Baldi,et al. Extended semen examinations in the sixth edition of the World Health Organization manual on semen analysis: contributing to the understanding of the function of the male reproductive system. , 2022, Fertility and sterility.
[4] OUP accepted manuscript , 2022, Human Reproduction Update.
[5] A. Agarwal,et al. The Sixth Edition of the WHO Manual for Human Semen Analysis: A Critical Review and SWOT Analysis , 2021, Life.
[6] O. Ishihara,et al. International Committee for Monitoring Assisted Reproductive Technologies world report: assisted reproductive technology, 2014†. , 2021, Human reproduction.
[7] A. Salonia,et al. European Association of Urology Guidelines on Male Sexual and Reproductive Health: 2021 Update on Male Infertility. , 2021, European urology.
[8] Abdullah M. Al Khayal,et al. Empirical therapy for male factor infertility: Survey of the current practice , 2021, Urology annals.
[9] J. Milic,et al. Health status is related to testosterone, estrone and body fat: moving to functional hypogonadism in adult men with HIV. , 2020, European journal of endocrinology.
[10] G. Wood,et al. Bariatric Surgery Impact on Reproductive Hormones, Semen Analysis, and Sperm DNA Fragmentation in Men with Severe Obesity: Prospective Study , 2020, Obesity Surgery.
[11] E. Baldi,et al. DNA Fragmentation in Viable and Non-Viable Spermatozoa Discriminates Fertile and Subfertile Subjects with Similar Accuracy , 2020, Journal of clinical medicine.
[12] H. Thaker,et al. Empirical medical therapy for idiopathic male infertility , 2020, F&S reports.
[13] D. Santi,et al. Follicle-Stimulating Hormone (FSH) Action on Spermatogenesis: A Focus on Physiological and Therapeutic Roles , 2020, Journal of clinical medicine.
[14] R. Ramasamy,et al. Serum 17-Hydroxyprogesterone is a Potential Biomarker for Evaluating Intratesticular Testosterone. , 2020, The Journal of urology.
[15] K. C. K. Lloyd,et al. DNA fragmentation index (DFI) as a measure of sperm quality and fertility in mice , 2020, Scientific Reports.
[16] S. Esteves,et al. An update on clinical and surgical interventions to reduce sperm DNA fragmentation in infertile men , 2020, Andrology.
[17] D. Santi,et al. FSH treatment of male idiopathic infertility: Time for a paradigm change , 2019, Andrology.
[18] L. Cree,et al. Incidence of high sperm DNA fragmentation in a targeted population of subfertile men , 2019, Systems biology in reproductive medicine.
[19] A. Calogero,et al. FSH dosage effect on conventional sperm parameters: a meta-analysis of randomized controlled studies , 2019, Asian journal of andrology.
[20] M. Nasr-Esfahani,et al. Zeta method: A noninvasive method based on membrane charge for selecting spermatozoa expressing high level of phospholipaseCζ , 2019, Andrologia.
[21] A. Lenzi,et al. Human sperm motility: a molecular study of mitochondrial DNA, mitochondrial transcription factor A gene and DNA fragmentation , 2019, Molecular Biology Reports.
[22] R. Rey,et al. Comparing the role of anti-Müllerian hormone as a marker of FSH action in male and female fertility , 2019, Expert review of endocrinology & metabolism.
[23] R. Ramasamy,et al. Can serum 17-hydroxyprogesterone and insulin-like factor 3 be used as a marker for evaluation of intratesticular testosterone? , 2019, Translational andrology and urology.
[24] E. Baldi,et al. Sperm DNA Fragmentation: Mechanisms of Origin. , 2019, Advances in experimental medicine and biology.
[25] D. Santi,et al. Sperm DNA fragmentation index as a promising predictive tool for male infertility diagnosis and treatment management - meta-analyses. , 2018, Reproductive biomedicine online.
[26] S. Esposito,et al. Inhibin B in healthy and cryptorchid boys , 2018, Italian Journal of Pediatrics.
[27] V. de Leo,et al. Recombinant FSH Improves Sperm DNA Damage in Male Infertility: A Phase II Clinical Trial , 2018, Front. Endocrinol..
[28] D. Goulis,et al. European Academy of Andrology guideline Management of oligo‐astheno‐teratozoospermia , 2018, Andrology.
[29] A. Lenzi,et al. The use of follicle stimulating hormone (FSH) for the treatment of the infertile man: position statement from the Italian Society of Andrology and Sexual Medicine (SIAMS) , 2018, Journal of Endocrinological Investigation.
[30] E. Baldi,et al. Treatment with human, recombinant FSH improves sperm DNA fragmentation in idiopathic infertile men depending on the FSH receptor polymorphism p.N680S: a pharmacogenetic study. , 2016, Human reproduction.
[31] A. Kopitar,et al. Sperm DNA fragmentation and mitochondrial membrane potential combined are better for predicting natural conception than standard sperm parameters. , 2016, Fertility and sterility.
[32] G. Belaaloui,et al. Sperm DNA Fragmentation and Standard Semen Parameters in Algerian Infertile Male Partners , 2015, The world journal of men's health.
[33] E. Baldi,et al. Investigation on the Origin of Sperm DNA Fragmentation: Role of Apoptosis, Immaturity and Oxidative Stress , 2015, Molecular medicine.
[34] Kristian Thorlund,et al. Reanalyses of randomized clinical trial data. , 2014, JAMA.
[35] A. Zini,et al. Sperm deoxyribonucleic acid damage in normozoospermic men is related to age and sperm progressive motility. , 2014, Fertility and sterility.
[36] Osamu Ishihara,et al. International Committee for Monitoring Assisted Reproductive Technologies world report: Assisted Reproductive Technology 2006. , 2013, Human reproduction.
[37] S. Greenland,et al. The table 2 fallacy: presenting and interpreting confounder and modifier coefficients. , 2013, American journal of epidemiology.
[38] A. Matsumoto,et al. Serum insulin-like factor 3 is highly correlated with intratesticular testosterone in normal men with acute, experimental gonadotropin deficiency stimulated with low-dose human chorionic gonadotropin: a randomized, controlled trial. , 2013, Fertility and sterility.
[39] N. Colacurci,et al. Recombinant human FSH reduces sperm DNA fragmentation in men with idiopathic oligoasthenoteratozoospermia. , 2012, Journal of andrology.
[40] Denny Sakkas,et al. Sperm DNA fragmentation: mechanisms of origin, impact on reproductive outcome, and analysis. , 2010, Fertility and sterility.
[41] P. Cohen-Bacrie,et al. Correlation between DNA damage and sperm parameters: a prospective study of 1,633 patients. , 2009, Fertility and sterility.
[42] C. O’Flaherty,et al. Characterization of sperm chromatin quality in testicular cancer and Hodgkin's lymphoma patients prior to chemotherapy. , 2008, Human reproduction.
[43] A. Matsumoto,et al. Serum 17-hydroxyprogesterone strongly correlates with intratesticular testosterone in gonadotropin-suppressed normal men receiving various dosages of human chorionic gonadotropin. , 2008, Fertility and sterility.
[44] R. Sram,et al. GSTM1 genotype influences the susceptibility of men to sperm DNA damage associated with exposure to air pollution. , 2007, Mutation research.
[45] C. Farquhar,et al. Gonadotrophins for idiopathic male factor subfertility. , 2007, The Cochrane database of systematic reviews.
[46] H. Katayose,et al. Successful pregnancy after ICSI with strontium oocyte activation in low rates of fertilization. , 2006, Reproductive biomedicine online.
[47] Thomas T. F. Huang,et al. An endogenous nuclease in hamster, mouse, and human spermatozoa cleaves DNA into loop-sized fragments. , 2005, Journal of andrology.
[48] K. Chaudhury,et al. Acrosin activity as a potential marker for sperm membrane characteristics in unexplained male infertility. , 2005, Fertility and sterility.
[49] Jens Peter Bonde,et al. Correlation between sperm motility and sperm chromatin structure assay parameters. , 2003, Fertility and sterility.
[50] H. Baker,et al. Frequency of defective sperm-zona pellucida interaction in severely teratozoospermic infertile men. , 2003, Human reproduction.
[51] N. Tarozzi,et al. Nature of DNA Damage in Ejaculated Human Spermatozoa and the Possible Involvement of Apoptosis1 , 2002, Biology of reproduction.
[52] D. Evenson,et al. Sperm chromatin structure assay: its clinical use for detecting sperm DNA fragmentation in male infertility and comparisons with other techniques. , 2002, Journal of andrology.
[53] A. Agarwal,et al. Characterization of subsets of human spermatozoa at different stages of maturation: implications in the diagnosis and treatment of male infertility. , 2001, Human reproduction.
[54] E. Clegg,et al. Utility of the sperm chromatin structure assay as a diagnostic and prognostic tool in the human fertility clinic. , 1999, Human reproduction.
[55] E. Nieschlag,et al. An activating mutation of the follicle-stimulating hormone receptor autonomously sustains spermatogenesis in a hypophysectomized man. , 1996, The Journal of clinical endocrinology and metabolism.
[56] F. Longo,et al. Chromatin structure-function alterations during mammalian spermatogenesis: DNA nicking and repair in elongating spermatids. , 1993, European journal of histochemistry : EJH.